C-8813

C-8813

Legal status
Legal status	In general: legal
Identifiers
IUPAC name trans-4-(p-Bromophenyl)-4-(dimethylamino)-1-(2-(thiophen-2-yl)ethyl)cyclohexanol
PubChem CID	11058633
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H26BrNOS
Molar mass	408.394 g/mol
3D model (JSmol)	Interactive image
SMILES c1cc(Br)ccc1C3(N(C)C)CCC(O)(CC3)CCc2sccc2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

C-8813 is a potent μ-opioid agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. It was found to be around 591x more potent than morphine in animal studies.

C-8813 has never been used in humans, but would be expected to produce effects similar to those of other potent opioid agonists, including strong analgesia, sedation, euphoria, constipation, itching and respiratory depression which could be harmful or fatal.

See Also

• 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol